CLOV vs LLY
Clover Health Investments Corp (CLOV) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
CLOV currently screens at market cap $1.55B. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the CLOV and LLY stock pages for the full models.
Not investment advice.